Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin

Acute lymphoblastic leukemia (ALL) is the most common malignancy affecting children and a major cause of mortality from hematopoietic malignancies in adults. A substantial number of patients become drug resistant during chemotherapy, necessitating the development of alternative modes of treatment. r...

Descripción completa

Detalles Bibliográficos
Autores principales: Parameswaran, Reshmi, Yu, Min, Lyu, Mi-Ae, Lim, Min, Rosenblum, Michael G., Groffen, John, Heisterkamp, Nora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376225/
https://www.ncbi.nlm.nih.gov/pubmed/22373785
http://dx.doi.org/10.1038/leu.2012.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376225/
https://www.ncbi.nlm.nih.gov/pubmed/22373785
http://dx.doi.org/10.1038/leu.2012.54

Ejemplares similares